Cargando…
Comparison of Immunogenicity and Safety of Four Doses and Four Double Doses vs. Standard Doses of Hepatitis B Vaccination in HIV-Infected Adults: A Randomized, Controlled Trial
BACKGROUND: HBV vaccination is recommended in HIV-infected adults with CD4+ cell count >200/mm(3) although the efficacy is only 33.3% -65%. We conducted a randomized, controlled trial to evaluate the efficacy and safety of three regimens of HBV vaccination at Chiang Mai University Hospital, Thail...
Autores principales: | Chaiklang, Kanokporn, Wipasa, Jiraprapa, Chaiwarith, Romanee, Praparattanapan, Jutarat, Supparatpinyo, Khuanchai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827227/ https://www.ncbi.nlm.nih.gov/pubmed/24265819 http://dx.doi.org/10.1371/journal.pone.0080409 |
Ejemplares similares
-
2231. Long-Term Immunogenicity of Four Doses and Four Double Doses vs. Standard Doses of Hepatitis B Vaccination in HIV-Infected Adults: An Extension of a Randomized Controlled Trial
por: Chaiwarith, Romanee, et al.
Publicado: (2018) -
Higher rate of long-term serologic response of four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: 4-year follow-up of a randomised controlled trial
por: Chaiwarith, Romanee, et al.
Publicado: (2019) -
Hepatitis B Vaccination Induced TNF-α- and IL-2-Producing T Cell Responses in HIV− Healthy Individuals Higher than in HIV+ Individuals Who Received the Same Vaccination Regimen
por: Chawansuntati, Kriangkrai, et al.
Publicado: (2018) -
Immunogenicity and safety of 4 vs. 3 standard doses of HBV vaccination in HIV-infected adults with isolated anti-HBc antibody
por: Laksananun, Nattinee, et al.
Publicado: (2019) -
Autoantibody to Interferon-gamma Associated with Adult-Onset Immunodeficiency in Non-HIV Individuals in Northern Thailand
por: Wongkulab, Panuwat, et al.
Publicado: (2013)